Skip to main content
. 2017 Mar;38(3):462–468. doi: 10.3174/ajnr.A5034

Table 5:

Cost-effectiveness analysis results: asymptomatic patient population subanalysisa

Strategy Cost ($) Incremental Cost ($) Effectiveness (QALYs) Incremental Effectiveness (QALYs) Incremental Cost-Effectiveness Ratio ($/QALY)
CTAP 145,247 13.86
TCD 156,272 11,024 13.51 −0.3517 Dominated
a

CTAP imaging strategy is used as the reference in the incremental cost-effectiveness results.